39,086 results on '"MESOTHELIOMA"'
Search Results
2. Selective TrkA Inhibitor VMD-928 to Treat TrkA Overexpression Driven Solid Tumors or Lymphoma
3. Evaluation of Cell Changes in Blood and Tissue in Cancers of the Lung, Esophagus and Lung Lining
4. Hemithoracic Irradiation With Proton Therapy in Malignant Pleural Mesothelioma (HIT-Meso)
5. Long Term Follow-up of Mesothelioma Patients and Their Family Members With Germline Mutations in BAP1 and Other Genes
6. Tissue Procurement and Natural History Study of Patients With Malignant Mesothelioma
7. TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study (TIGER Meso)
8. Pleurectomy/Decortication (Neo) Adjuvant Chemotherapy and Intensity Modulated Radiation Therapy to the Pleura in Patients With Locally Advanced Malignant Pleural Mesothelioma
9. SW-682 in Advanced Solid Tumors
10. MEDI5752 in Combination With Carboplatin Plus Pemetrexed in Unresectable Pleural Mesothelioma (eVOLVE-Meso)
11. Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomatoid Mesothelioma
12. Neoadjuvant Immune Checkpoint Blockade in Resectable Malignant Pleural Mesothelioma
13. Pevonedistat Alone and in Combination With Chemotherapy in Patients With Mesothelioma
14. Study of Nivolumab Combined With Ipilimumab Versus Pemetrexed and Cisplatin or Carboplatin as First Line Therapy in Unresectable Pleural Mesothelioma Patients (CheckMate743)
15. A Phase II Clinical Trial to Evaluate Safety and Efficacy of XmAb20717 in Advanced Rare Cancers
16. Testing the Addition of an Anti-cancer Drug, BAY 1895344, to the Usual Chemotherapy Treatment (Cisplatin, or Cisplatin and Gemcitabine) for Advanced Solid Tumors With Emphasis on Urothelial Cancer
17. Atezolizumab, Pemetrexed Disodium, Cisplatin, and Surgery With or Without Radiation Therapy in Treating Patients With Stage I-III Pleural Malignant Mesothelioma
18. Autologous Dendritic Cell Vaccination in Mesothelioma (MESODEC)
19. Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin
20. Malignant Pleural Disease Treated With Autologous T Cells Genetically Engineered to Target the Cancer-Cell Surface Antigen Mesothelin
21. Pemetrexed Disodium and Cisplatin With or Without Cediranib Maleate in Treating Patients With Malignant Pleural Mesothelioma
22. Study of Cadonilimab Combined With Chemotherapy in Recurrent / Refractory Pleural Mesothelioma
23. Evaluation of Response by FLT PET in Mesothelioma (FLT-MM)
24. Integration of the PD-L1 Inhibitor Atezolizumab and WT1/DC Vaccination Into Platinum/Pemetrexed-based First-line Treatment for Epithelioid Malignant Pleural Mesothelioma (Immuno-MESODEC)
25. SynKIR-110 for Mesothelin Expressing Ovarian Cancer, Cholangiocarcinoma or Mesothelioma
26. Chemotherapy With or Without Immunotherapy for Peritoneal Mesothelioma
27. Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors
28. A Study of Safety and Efficacy of KFA115 Alone and in Combination With Pembrolizumab in Patients With Select Advanced Cancers
29. A Phase I Study of IAG933 in Patients With Advanced Mesothelioma and Other Solid Tumors
30. Phase II Nivolumab and Ramucirumab for Patients With Previously-Treated Mesothelioma
31. A Study of TAK-500 With or Without Pembrolizumab in Adults With Select Locally Advanced or Metastatic Solid Tumors
32. Study to Evaluate VT3989 in Patients With Metastatic Solid Tumors Enriched for Tumors With NF2 or mNF2 Gene Mutations
33. Pembrolizumab in Treating Patients With Malignant Mesothelioma
34. Study of Pembrolizumab (MK-3475) in Participants With Advanced Solid Tumors (MK-3475-158/KEYNOTE-158)
35. Randomized, Double-blind Study Comparing Tremelimumab to Placebo in Subjects With Unresectable Malignant Mesothelioma (Tremelimumab)
36. Donor Natural Killer Cells, Cyclophosphamide, and Etoposide in Treating Children and Young Adults With Relapsed or Refractory Solid Tumors
37. NM32-2668 in Adult Patients With Selected Advanced Solid Tumors
38. eRAPID: Online Symptom Reporting in Lung Cancer
39. Rapid Autopsy and Procurement of Cancer Tissue
40. A Study of SGN-BB228 in Advanced Melanoma and Other Solid Tumors
41. BEAT-meso: Bevacizumab and Atezolizumab in Malignant Pleural Mesothelioma (BEAT-meso)
42. A Study of NX-1607 in Adults With Advanced Malignancies
43. Individualized Response Assessment to Heated Intraperitoneal Chemotherapy (HIPEC) for the Treatment of Peritoneal Carcinomatosis From Ovarian, Colorectal, Appendiceal, or Peritoneal Mesothelioma Histologies
44. Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB099280 in Participants With Advanced Solid Tumors
45. PRO1184 for Advanced Solid Tumors (PRO1184-001)
46. Using E-Nose Technology to Measure Response to Treatment in People With Malignant Pleural Mesothelioma
47. Study of MT-8421 as Monotherapy and in Combination With Nivolumab in Patients With Selected Advanced Solid Cancer Types
48. A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors
49. Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
50. Pharmacokinetic Study of Lurbinectedin in Combination With Irinotecan in Patients With Selected Solid Tumors
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.